Breast Surgery (Breast Surgical Oncology) — Specialty Profile

Exploratory, not prescriptive. This profile blends hard data (pay, match rates, burnout, demographics — each sourced and dated) with generalizations and synthesized online opinion about culture and "who fits." It's here to help you get curious and go find out for yourself — not to tell you who to become. Numbers marked ⟳ verify change every year; check the linked source before you quote one. Last reviewed: 2026-07-25.

Subspecialty fellowship of General Surgery (SSO-accredited breast surgical oncology).

Also called: breast surgery, BSO, breast surg-onc. You do not match into this from medical school; you reach it through general surgery, then a 1-year fellowship. Organ system: the breast (oncologic and benign).

The 30-second version

Breast surgery is the rare corner of surgery where "surgeon" and "controllable life" genuinely belong in the same sentence. It's largely elective, outpatient, oncologic surgery (lumpectomies, mastectomies, sentinel-node biopsies, working up and coordinating breast-cancer care) with very little of the emergent, 2-a.m., someone-is-bleeding-out drama that defines broad general surgery. You get there the standard way you'd reach most surgical subspecialties: five years of general surgery residency, then one dedicated breast fellowship year. The honest catch is money. Breast surgeons typically earn less than broad general surgeons, because the case mix is lower-RVU and outpatient. That trade is the whole personality of the field: you buy predictable hours, minimal call, an oncologic mission, and years-long patient relationships with a real pay cut. It's a lifestyle-and-focus choice rather than a paycheck-maximizing one.

Quick dashboard (details and sources below)
Training after med school GS residency (5) + Breast fellowship (1) = 6 yrs after med school
Total from college start ~14 years (4 undergrad + 4 med school + 5 GS residency + 1 fellowship)
Accreditation Fellowship is SSO-accredited, NON-ACGME; you're board-certified in General Surgery (ABS) — there is no separate breast board certificate ⟳
Competitiveness (as a surgical fellowship) Moderate — ~93 positions fill 100%, but ~30% of applicants go unmatched ⟳
Typical full-time pay The two instruments are ~$160k apart: ~$465,000 (ASBrS 2018 mean carried forward at 3%/yr) vs ~$303,000 median (Salary.com, base-weighted). No breast-specific survey since 2018 ⟳
Pay range (structure) 10th ~$239k · median ~$303k · 90th ~$367k (Salary.com); top mixed/ownership practices $500k+ ⟳
The pay reality Subspecializing reduces pay here: ASBrS found 100%-breast practice earns less than breast plus other general surgery. The size of the gap against broad general surgery (~$442k–$483k) is not published ⟳
Lifestyle Among the most controllable in all of surgery: elective, outpatient, minimal emergent call
Burnout Runs lower than broad general surgery ⟳
% women ~90% of fellows; ~62% of ASBrS members — one of the most female surgical fields ⟳

What they actually do

Breast surgical oncologists manage benign and malignant breast disease, surgically and as the coordinating quarterback of a cancer team. The bread-and-butter operations are lumpectomy/partial mastectomy, mastectomy (simple, skin-sparing, nipple-sparing), sentinel lymph node biopsy and axillary dissection, and image-guided and excisional biopsies. Increasingly the work includes oncoplastic breast-conserving surgery, removing the cancer while shaping the breast so it looks good afterward, plus management of high-risk lesions and hereditary-risk (BRCA and related) patients.12

A large share of the job is not in the OR at all. Breast oncology is cognitively front-loaded: tumor boards, genetics discussions, imaging review, and heavy multidisciplinary coordination, pairing with plastic and reconstructive surgery for reconstruction, and with medical and radiation oncology for systemic and radiation therapy. Much of this coordinating work generates no RVUs, which is exactly why the field's pay ceiling sits below procedure-heavy surgery even though the cognitive and relational load is high.13

Representative procedures: lumpectomy / partial mastectomy · simple, skin-sparing, and nipple-sparing mastectomy · sentinel lymph node biopsy · axillary lymph node dissection · image-guided and excisional breast biopsy · oncoplastic breast-conserving techniques · high-risk-lesion excision and prophylactic surgery · (emerging) cryoablation of small tumors.12

A day in the life: It's largely scheduled and largely daytime, with clinic days and OR days you can plan a week around. Many operations are same-day and outpatient, so the case list doesn't explode overnight the way acute-care surgery does. You move between clinic (new diagnoses, survivor follow-ups, high-risk surveillance), the OR (mostly shorter elective cases), and the conference room (tumor board, coordinating with oncology/radiology/pathology/plastics). Call, where it exists, is light, because breast disease rarely needs someone in the OR at 3 a.m. Unlike much of general surgery, you follow the same patients for years.3

The training path & time to completion

Medical school (4 yrs) → General Surgery residency (5 yrs) → Breast Surgical Oncology fellowship (1 yr) = 6 years after medical school. You reach breast surgery through general surgery, and there is no direct match into it from med school.4

  • The fellowship is 1 year and is SSO-accredited (Society of Surgical Oncology), NOT ACGME-accredited. This is an important, easy-to-miss distinction: unlike your residency (ACGME), the breast fellowship runs under the specialty society, and applications go through the SSO "Breast Match" administered by National Matching Services.45
  • Board certification is in General Surgery, from the American Board of Surgery (ABS). Earned via the residency plus the ABS Qualifying and Certifying exams. Completing the breast fellowship does not confer a separate board certificate; there is no distinct ABS breast certification. Your credential, formally, is "general-surgery boarded."4
  • Total from the start of college: ~14 years (4 undergrad + 4 med school + 5 residency + 1 fellowship).

How competitive is it? (as a surgical fellowship)

Breast surgery is moderately competitive, and the shape of the competition is different from a residency match, so read it on its own terms. Every position and every program fills, but a meaningful minority of applicants don't match.

The most recent cycle (2026 Breast Match, released July 15, 2026):5

  • 93 positions offered, 93 filled (100%) across 64 programs, so every program filled.5 ⟳
  • 135 applicants participated; 93 matched (69%), 42 unmatched (31%). The applicant pool exceeds positions by roughly 45%.5 ⟳
  • The market is application-heavy: applicants submitted an average of 41.6 applications each, and programs ranked about 19 applicants per position, signals of a saturated, high-effort match.5 ⟳
  • 2025 was tighter still on the applicant side: 92 positions (100% filled), but 60 of 152 participants unmatched (39%).6 ⟳
  • Cost is a real barrier: in the 2024 match survey, 48.3% of matched applicants estimated spending ≥$5,000 on interviews.7 ⟳

The honest read: all positions fill, so programs never go wanting, but ~30% of the people who want breast surgery in a given year don't get it, and the ones who do have applied broadly and spent real money doing it. It's competitive for fit rather than by volume, and it isn't a formality either. And because you get here through general surgery, the first competitive gate is matching into a GS residency at all.

Compensation — the robust version, and the honest trade

Here is the fact that makes breast surgery unusual: it is a subspecialty where total compensation is typically LOWER than the broad specialty you trained in. Most fellowships raise your pay; this one generally doesn't. Naming that plainly is the single most useful thing this section can do.13

Why the pay is lower, in two structural reasons:

  1. The case mix is lower-RVU and largely outpatient. Breast operations generate fewer work-RVUs per unit time than the high-acuity, emergency, and complex abdominal/vascular/HPB work that drives general-surgery income. There's little to no lucrative night/emergency/trauma volume.1
  2. Pay tracks volume and wRVUs, and pure-breast practice caps both. The clearest single data point: the ASBrS survey found surgeons who practice 100% breast earned LESS than those doing a mix of breast + other general surgery. Focusing reduces pay.18

National number. The best breast-specific primary source is the American Society of Breast Surgeons (ASBrS) compensation survey: mean annual compensation $370,555, from a survey emailed to 2,676 active members in October 2018, to which 38.2% responded (n = 1,022), up from $330,700 in 2013.18 October 2018 to mid-2026 is about 7.75 years, so carrying that mean forward at 3% a year lands at roughly $465,000.9 ⟳ Read it as an upper bound on what a pure-breast practice pays rather than a measure of it, because 61% of those respondents practiced breast exclusively and the other 39% did breast plus other general surgery, which the same survey found pays more.1 The one commercial aggregator left on this page runs far lower: Salary.com's median is $303,051 (July 2026), base-weighted HR benchmark data used here for percentile shape rather than for level.1011 Those two anchors are about $160,000 apart and there is no breast-specific total-compensation survey newer than 2018, so this page carries both rather than splitting them. ⟳

The spread (structure, Salary.com July 2026): 10th pct $239,017 · 25th $269,533 · median $303,051 · 75th $336,708 · 90th $367,351.10 This page used to set a ZipRecruiter ladder beside it; job-board postings have no panel behind them and it is gone.11 Top-of-market, meaning high-volume mixed practice with favorable geography and ownership or partnership, can reach $500,000+, which is above the ASBrS mean carried forward but not far above it. Note the distribution is tighter than broad general surgery: fewer sky-high outliers, because there's little emergency or complex-case upside.12 ⟳

The comparison that defines the field, and what it will and won't carry. Broad general surgery averages ~$442,000 (Medscape 2025) and $482,574 (Doximity 2025); the broad "oncology" line runs even higher ($502,465, Doximity).1314 This page used to put a breast surgical oncologist $50,000–$150,000/yr below the average broad general surgeon. That figure does not survive the corrected arithmetic above: at roughly $465,000 the inflated-forward ASBrS mean lands inside general surgery's own band, and the two instruments survey different populations anyway, one a breast society's own members and the other general surgeons at large. What holds the field's reputation up is a comparison made inside a single survey, on a single population: ASBrS found that surgeons practicing 100% breast earned less than those doing breast plus other general surgery. Every base-weighted aggregator points the same way, Salary.com's $303,051 among them. So the direction is well supported and the size of the gap is not published anywhere.1101314 ⟳

Practice setting (ASBrS 2014, in 2013 dollars, which is 13 years back from mid-2026, so add about 47% at 3% a year to modernize): hospital-employed $368,000 (highest) · multispecialty group $346,600 · academic $308,500 · single-specialty private $285,800 · solo private practice $249,200 (lowest, because pure-breast solo lacks the volume and ancillary leverage to compete). Academic sits modestly below hospital-employed and community roles, traded for research and protected time. Notably, the 2018 survey found practice-setting type was not a significant independent pay predictor once volume, wRVUs, experience, and gender were controlled, so what you produce matters more than the label.815 ⟳

Geography is weaker here than in most fields. The ASBrS 2018 multivariate analysis found geographic region was NOT a statistically significant predictor of pay once volume, experience, and gender were controlled, a notable contrast to procedure-heavy specialties where geography is huge. Aggregators show the usual directional signal (top states DC ~$335,538, California ~$334,265, Massachusetts ~$329,810 per Salary.com), but these are small self-reported samples, so treat them as low-confidence.110 ⟳

What actually drives your pay (ASBrS 2018 multivariate, significant predictors): more years in practice · higher annual cancer case volume · higher wRVUs · practicing breast plus other general surgery (mixed rather than 100% breast) · and, documented and uncomfortable, male gender.1

The gender pay gap is well-documented here, and it matters because the field is majority-female. The 2014 survey found adjusted expected income of $378,000 (male) against $310,000 (female), a ~$68,000 gap, and male gender remained a significant positive pay predictor in 2018.815 ⟳

How you're paid. Predominantly salary + wRVU-productivity bonus in employed/hospital models; base + bonus + profit-sharing in group/private (Payscale shows bonus components $3k–$58k and profit-sharing $4k–$139k).16 Demand tailwinds from rising breast-cancer incidence, screening volume, and the growth of dedicated breast centers support stable employment and gradual pay growth, but the outpatient, low-RVU structure keeps the ceiling below procedure-heavy surgery.9

Lifestyle & the trade you're actually buying

This is the clearest yes when people ask whether there is any surgical field with a real life, and not as a consolation prize.3

  • Mostly elective and outpatient. The work is scheduled oncologic surgery; many operations are same-day. That means predictable OR days and clinic days rather than a case list that detonates overnight.3
  • Minimal emergent overnight call. Breast disease rarely needs the OR at 3 a.m. Call, where it exists, is light and plannable, a stark contrast to trauma, acute-care, and broad general surgery. (In the UK, breast surgeons often carry no on-call at all and describe a roughly 8-to-6, Monday-to-Friday rhythm; US practice is busier but the underlying shape is similarly predictable.)3
  • Schedule control is the headline draw. Repeatedly cited as the reason surgeons, especially those raising kids, choose it. You can meaningfully build your own week.3
  • Career longevity is excellent for surgery. Cases are generally shorter and far less physically brutal than long open abdominal or vascular work, so the field is kinder to a body across a 25–30 year career, and you can genuinely practice it into your 60s.3

Lifestyle rating: 4/5. High on both predictability and control, which is rare for any surgical field; short of a 5 only because it's still surgery (OR days, cancer stakes, and the emotional weight below).

Wellbeing — the part that runs counter to surgery's reputation

  • Burnout runs lower than broad general surgery. Surgical oncologists as a group report meaningful career satisfaction, and the manageable schedule and lack of emergent chaos remove a big chunk of what drives surgeons to burn out. (Balch et al. found surgical oncologists compared favorably with other surgical specialties on burnout and satisfaction; breast, as a controllable-lifestyle subset, sits at the better end.)17 ⟳
  • "Would choose it again" is high. A mission people believe in + sustainable hours + durable patient relationships tends to produce surgeons glad they picked it.3 ⟳
  • Long-term relationships are a core source of meaning. Unlike much of general surgery, where you fix it, discharge, and rarely see them again, breast surgeons follow cancer patients and survivors for years.3
  • Multidisciplinary by design. You work constantly alongside medical and radiation oncology, radiology, pathology, plastics, and genetics. People who like caring for a whole person as part of a team (rather than a lone operator) find this deeply satisfying.3
  • The honest counterweight: it's emotionally heavy. You deliver cancer diagnoses and walk with people through hard outcomes for years, and the same continuity that gives the field meaning also means you carry the losses.3

Who's in the field (demographics)

  • Women: one of the most female surgical fields in the US. ~90% of breast fellows are women, and ~62% of ASBrS members were female (2019), against only ~20% of practicing general surgeons. The contrast is now mostly at the practicing level: general surgery residency has reached parity, with 5,024 of 10,074 active residents women, 49.9%, in academic year 2024-25.1819 Breast surgery is still one of the very few surgical spaces where women are the clear majority, and among trainees it is a majority inside a field that is no longer male-dominated at that stage. ⟳
  • Women also hold real leadership, unusually for surgery: 73% of breast-fellowship program directors are women, and at the ASBrS annual meeting (2009–2019 avg) women were 44.8% of the Board, 41.7% of committee chairs, and >70% of scientific first-authors.2019 ⟳
  • IMG / DO / URiM: not reported. No official match-level breakdown of IMG, DO, or URiM representation among breast-fellowship applicants or matched fellows was located in public SSO or natmatch reporting as of mid-2026. The Breast Match statistics publish counts and ranking behavior but not medical-school type or race and ethnicity. The general-surgery feeder pipeline skews heavily US-MD with smaller DO and IMG shares; breast-specific figures should be treated as not reported, ⟳ verify, rather than estimated.56

Culture, personality & the online stereotypes

Who gravitates here: surgeons, and this field is heavily women, who want to genuinely operate and do real oncologic surgery, but who also want lasting patient relationships and a life outside the hospital. People drawn specifically to the breast-cancer mission and to coordinated, multidisciplinary cancer care rather than solo heroics. It notably attracts people who found broad general surgery's lifestyle unsustainable but didn't want to leave the OR to get their life back. As always, plenty of people in the field do not fit any single mold.3

The gender skew is stark: women are the majority of members, the vast majority of fellows, and a large share of leadership. Some of that history carries baggage. Breast surgery was long dismissed by (mostly male) surgeons as less prestigious than "big" general or trauma cases, and decades ago some women were effectively steered into it rather than choosing it freely. The modern reality is different: it's now a chosen, competitive, technically rich field, but the old framing still echoes online. (As always: this is a broad pattern about who the field has drawn, not a claim about who any individual is or should be, and plenty of surgeons don't fit the profile at all.)318

The stereotypes. Community caricatures rather than facts, each with an unfair edge:

  • "The controllable-lifestyle surgical subspecialty." Reality: broadly true, and unusually so for surgery, but it's still cancer surgery with real stakes and emotional weight rather than an easy specialty.
  • "The surgery you can actually do as a parent." Reality: the predictable schedule is real and is discussed openly rather than in whispers, but framing the whole field around parenting flattens people who chose it for the oncology or the technique.
  • "Less RVU, less pay, far better hours." Reality: accurate as a trade, but sells short the oncologic complexity and the coordinating "quarterback" role.
  • "'Less serious' / one-organ surgery." Reality: this is the cynical take that gets pushed back on hardest, because it ignores the oncologic complexity, the emotional load of cancer care, and the genuine artistry of oncoplastic work.
  • "Female-dominated" (said sometimes approvingly, sometimes reductively). Reality: it is the rare female-majority surgical field, a fact rather than a knock, and reducing the whole specialty to that misses the medicine.

What people say online (synthesized and paraphrased, not quotes): Across trainee and physician forums the picture is consistent. Breast surgery is the go-to example when someone asks whether any surgical field has a real lifestyle, and it is treated as the clearest yes. People openly acknowledge it pays less than broad general surgery and frame the trade as buying hours and predictability with dollars. It's discussed, without euphemism, as a strong fit for people who want kids and a surgical career at the same time. There's some cynicism, with occasional posts framing it as "less serious" surgery, but that usually gets corrected by people pointing to the oncologic complexity, the emotional weight of cancer care, and the real technical skill (oncoplastic work especially). The one-year fellowship and steady, broad job demand are seen as practical wins. The through-line: people who wanted to stay in the OR and have a life, and found this was how.3

Voices from the field. Paraphrased from public writing, with links to the originals:

  • A breast surgical oncologist writing for in-Training describes being drawn in by attendings who kept the same patients for years and built real trust, a contrast to general surgery's one-and-done follow-up, plus the teamwork with pathology, radiology, plastics, and oncology, and the humanistic side of walking cancer patients through their journey.21
  • Medscape's reporting on female leadership traces how breast surgery became the surgical exception where women reached majority representation and leadership, driven partly by the field's predictable hours and family-compatibility.18
  • ASBrS-linked scholarship documents women as the sustained majority of participants, presenters, and a growing share of leadership at the society over the past decade.19
  • Physician essays out of the ASBrS annual meeting (Doximity Op-Med) emphasize the field's community, skill-building, and evolving techniques, oncoplastic approaches and cryoablation among them.2223

Why people choose it / why people leave

Why choose it: one of the best lifestyles in all of surgery, being predictable, largely elective, and minimal on emergent call · deep, years-long relationships with patients and survivors · a mission people believe in (breast cancer is common and the work is high-impact) · multidisciplinary teamwork rather than solo operating · a short path relative to other subspecialties (GS + 1 year) with steady, broad job demand · excellent career longevity, sustainable into your 60s · you often become the "quarterback" of a patient's whole cancer team.3

Why leave or avoid it: pay is typically lower than broad general surgery, and the fellowship doesn't reliably buy an income bump the way many subspecialties do · a documented gender pay gap in a majority-female field · narrow scope, since you essentially operate on one organ, which some find limiting or repetitive · emotionally heavy, since you deliver cancer diagnoses and carry hard outcomes over years · less of the acute, adrenaline, "big case" surgery some people went into surgery for.13

Best fit if: you want to be a surgeon and have a genuinely livable schedule and family life · you're drawn to oncology and long-term relationships, not just the technical fix · you value team-based care and are motivated by the breast-cancer mission · you're at peace trading maximum income for hours and predictability.3

Not for you if: you want maximum surgical income and RVU volume · you crave variety, big open cases, trauma, or acute unpredictability · repetitive, single-organ focus would bore you · carrying the emotional weight of cancer patients long-term would wear you down.3

The FLI angle — Breast Surgery for first-gen, low-income & immigrant students

This is a genuinely interesting option for an FLI premed who wants surgery but also wants a life and, eventually, a family, without the punishing hours of broad general or trauma surgery.

Where breast surgery fits FLI realities well:

  • A rare combination: a surgical career with a controllable, sustainable lifestyle, reached via a standard general surgery residency plus one extra fellowship year, into a field with strong, steady demand. Breast cancer is common everywhere, so jobs exist well beyond the big coastal cities.3
  • Career longevity protects your earning years. When you're the family's financial anchor, a field you can practice sustainably for decades, because the cases are shorter and physically gentler, is worth a great deal.3
  • Geographic flexibility. Dedicated breast centers and health-system breast programs exist across the country, so you can practice near family or in a lower-cost region, not just a handful of academic hubs. (And unlike most fields, geography isn't a big pay lever here, so choosing where to live costs you less financially.)13

Risks to name honestly:

  • The pay is the catch, and it's the whole point to understand. Compensation is typically lower than broad general surgery (median around the low-$300Ks on conservative aggregators, ~$370k–$400k+ on the breast-society survey inflated forward), and the fellowship doesn't reliably raise your pay versus just practicing general surgery. Think of it as a lifestyle-and-focus choice rather than a money-maximizing one. That's still a very comfortable physician income that comfortably supports a family, just a real trade against the highest-earning surgical paths.1024
  • The path is long and the first gate is general surgery. You don't reach breast surgery directly. It's 5 years of demanding GS residency (which you have to match into first) then a competitive 1-year fellowship where ~30% of applicants go unmatched and the interview trail can cost ≥$5,000. That's more years of trainee pay before the attending income arrives.57
  • A documented gender pay gap exists in this majority-female field, which matters going in, especially if you’ll be negotiating your own first contract.8
  • For a breadwinner, the calculus is nuanced: the hours, predictability, and longevity may be worth more to your actual life than the salary delta, but go in with eyes open about that delta.24

Bottom line: breast surgery is one of the few ways to be a surgeon and still have a controllable, sustainable life and a family, reachable through a standard general surgery residency plus a single fellowship year, into steady nationwide demand. The trade is real and specific: you'll likely earn meaningfully less than a broad general surgeon, and the fellowship won't fix that. If the lifestyle, the mission, and the longevity are worth more to you than the top surgical paycheck, it's a rare and honest fit. Shadow a breast surgeon's clinic and OR days before you commit. The mix is the whole point, and it's not what most people picture when they picture "surgery."

Sub-focuses within breast surgery

The field doesn't fragment into formal sub-subspecialties, but there are recognizable leanings within it:24

  • Oncoplastic surgery. Blending cancer removal with cosmetic/reconstructive technique so the breast looks good afterward; a growing sub-focus that adds real artistry to the oncologic work.222
  • High-risk / genetics clinics. Managing BRCA and other hereditary-risk patients: prophylactic surgery, surveillance, and counseling. Even more clinic-heavy and relationship-driven, arguably the most lifestyle-friendly corner of an already lifestyle-friendly field.24
  • Emerging non-operative techniques. E.g., cryoablation (freezing small tumors), which is expanding the field beyond the traditional OR.23

Formally, all of these are practiced under general-surgery board certification, and none is a separate accredited subspecialty.4

Sub-subspecialties & fellowships

There are no formal sub-subspecialties under breast surgery. Everyone here remains certified through general surgery, and the differences between practices are leanings rather than credentials.

  • Oncoplastic surgery. Combining the cancer operation with reconstructive technique, often learned through courses and case volume rather than a separate fellowship year.
  • High-risk and genetics clinics. A largely non-operative practice built around surveillance and risk-reducing decisions for patients with a family history or a known mutation.
  • Emerging ablative techniques. Cryoablation and similar approaches are early enough that access depends on the institution rather than on any credential you can train for.

Fun facts

  • In the rarest of things, a surgical field where women are the majority: ~62% of ASBrS members and ~90% of fellows are women, nearly the inverse of general surgery's ~20%.18
  • It's the fellowship that usually lowers your pay. Breast surgeons typically earn less than broad general surgeons, the opposite of the "subspecialize → earn more" pattern, and one of the clearest lifestyle-for-money trades in medicine.1
  • One year, and no new board. After a full general surgery residency, breast is a single dedicated fellowship year, and it confers no separate board certificate, your credential stays "general-surgery boarded."4
  • It's SSO-accredited, not ACGME. Unusually, the fellowship runs under the specialty society (Society of Surgical Oncology) rather than the body that accredits your residency.4
  • A specialty that rewrote its own reputation. From a corner of general surgery once dismissed as less prestigious into a chosen, competitive, technically rich field.18
  • You're often the quarterback of a patient's cancer team, coordinating radiology, pathology, medical and radiation oncology, plastics, and genetics, which is unusual for a surgeon.3

Sources

Footnotes

  1. ASBrS 2018 Compensation Survey — mean $370,555; significant pay predictors (years in practice, case volume, wRVUs, mixed-vs-100%-breast, male gender); practice-setting type NOT significant; 100%-breast earns less; geographic region NOT a significant predictor. "The 2018 Compensation Survey of the American Society of Breast Surgeons," Annals of Surgical Oncology (2019). https://link.springer.com/article/10.1245/s10434-019-07546-x ↩ ↩2 ↩3 ↩4 ↩5 ↩6 ↩7 ↩8 ↩9 ↩10 ↩11 ↩12 ↩13 ↩14

  2. Scope of work / procedures (lumpectomy, mastectomy, sentinel node, oncoplastic, biopsy, high-risk). SSO — Breast Surgical Oncology Fellowship (fellows page), accessed 2026. https://surgonc.org/fellows/breast-surgical-oncology-fellowship/ ↩ ↩2 ↩3

  3. Lifestyle, wellbeing, culture, day-in-the-life, decision guide, and online sentiment. Medscape, "Glass Ceiling Shattered by Female Breast Surgeons" (2020, incl. UK 8-to-6/no-call description). https://www.medscape.com/viewarticle/940147 (synthesized with r/surgery, r/medicalschool, SDN community themes — paraphrased, not quoted). ↩ ↩2 ↩3 ↩4 ↩5 ↩6 ↩7 ↩8 ↩9 ↩10 ↩11 ↩12 ↩13 ↩14 ↩15 ↩16 ↩17 ↩18 ↩19 ↩20 ↩21 ↩22 ↩23

  4. Training pathway, 1-year fellowship, SSO (non-ACGME) accreditation, and General Surgery/ABS board certification with no separate breast certificate. SSO — BSO Fellowship for Current & Prospective Programs. https://surgonc.org/fellows/breast-surgical-oncology-fellowship/breast-surgical-oncology-fellowship-for-current-and-prospective-programs/ ; American Board of Surgery (no breast certificate). https://www.absurgery.org/ ; SSO Breast Match program overview (2025–26 cycle). https://natmatch.com/ssobreast/documents/program_overview.pdf ↩ ↩2 ↩3 ↩4 ↩5 ↩6

  5. 2026 Breast Match — 93 positions offered/filled (100%); 64 programs; 135 participated, 93 matched (69%), 42 unmatched (31%); 41.6 avg applications; 19.0 applicants ranked per position. 2026 Breast Match Statistics. https://natmatch.com/ssobreast/stats/2026stats.pdf (2026) ↩ ↩2 ↩3 ↩4 ↩5 ↩6 ↩7

  6. 2025 Breast Match — 92 positions offered/filled (100%); 152 participated, 92 matched, 60 unmatched (39%); 39.0 avg applications. 2025 Breast Match Statistics. https://natmatch.com/ssobreast/stats/2025stats.pdf (2025) ↩ ↩2

  7. 2024 Breast Match analysis — 89 matched, 64 programs; 48.3% of matched applicants spent ≥$5,000 on interviews. "Analysis of the 2024 Breast Surgical Oncology Fellowship Match," Annals of Surgical Oncology (2025); PubMed 40849385. https://pubmed.ncbi.nlm.nih.gov/40849385/ ; https://link.springer.com/article/10.1245/s10434-025-18043-9 ↩ ↩2

  8. ASBrS 2014/2015 Salary Survey — mean income $330,700 (2013); by-setting breakdown; gender gap $378k (M) vs $310k (F). "What is a Breast Surgeon Worth? A Salary Survey of the American Society of Breast Surgeons," Annals of Surgical Oncology (2015). https://link.springer.com/article/10.1245/s10434-015-4720-z ; https://pubmed.ncbi.nlm.nih.gov/26202565/ ↩ ↩2 ↩3 ↩4 ↩5

  9. Pay-growth trend and 2026 extrapolation — broad physician pay +3.7% (2024, Doximity) / ~3% (2025, Medscape); demand tailwinds. https://www.fiercehealthcare.com/finance/physician-pay-sees-modest-37-bump-2024-here-are-pay-ranking-metro-area-and-specialty ; https://www.doximity.com/reports/physician-compensation-report/2025 (2025 / 2024 data) Corrected 2026-08-17: both of this page's inflation computations understated, and both did so in the direction of the page's own thesis. The survey's own Methods section states it was emailed to 2,676 active members in October 2018 (Ann Surg Oncol 2019, PMID 31342382), which is about 7.75 years before mid-2026, so $370,555 at 3% a year reaches about $465,000. This page said "the low-to-mid $400,000s," which corresponds to roughly 2.6 to 6.6 years and set the top of a $360,000–$400,000 dashboard range. The practice-setting line said 2013 dollars needed "~15–25%" added; 2013 to mid-2026 is 13 years and 1.03¹³ is 1.469, so the modernizer is about +47%. Both are now stated with their spans so the arithmetic is checkable. The consequence is recorded on the page: at $465,000 the ASBrS mean sits inside broad general surgery's own $442,000–$483,000 band, so the "$50,000–$150,000/yr less" gap this page used to assert has been removed rather than rounded down. What replaced it is the comparison ASBrS made internally, where 100%-breast practice earns less than breast plus other general surgery, which does not depend on reconciling two surveys of two populations. ↩ ↩2

  10. Salary.com "Breast Surgical Oncologist" — median $303,051; percentile ladder (10th $239,017 → 90th $367,351); top states DC/CA/MA. https://www.salary.com/research/salary/hiring/breast-surgical-oncologist-salary (July 2026) On Salary.com: its CompAnalyst benchmark is HR-reported employer survey data blended with job-posting data, not a physician panel. It is base-weighted and so runs low against total-compensation surveys, and it is used here for percentile structure rather than for levels. ↩ ↩2 ↩3 ↩4 ↩5

  11. Removed 2026-08-13. This footnote carried a ZipRecruiter average of $341,808 and a percentile ladder for "Breast Surgical Oncologist." Job postings are title-matched with no panel or sample size. The percentile structure on this page now rests on Salary.com's HR-reported benchmark, and the national figure on the ASBrS survey. Corrected 2026-08-17: that removal reached this footnote and one body sentence and missed two others. The $341,808 was still printed as current data in the national-number paragraph, and the geography paragraph still cited ZipRecruiter's top metros; both are gone now. The figure was also load-bearing while it was supposed to be deleted, because the dashboard's typical-pay range was defined as sitting between the commercial aggregators and the inflated-forward ASBrS mean, and ZipRecruiter was one of the two anchors. That range has been re-derived from what is left. ↩ ↩2

  12. Range/spread synthesis and $500k+ top-of-market exception; ICGI bands. ICGI, "How Much Does a Breast Surgeon Make?" https://www.icgi.org/how-much-does-a-breast-surgeon-make/ (March 2026) ↩

  13. General surgery (broad) $442,000 and ~3% growth (Medscape Compensation Report 2025), via Becker's. https://www.beckershospitalreview.com/compensation-issues/29-physician-specialties-ranked-by-annual-compensation-medscape/ (2025) ↩ ↩2

  14. General surgery (broad) $482,574 and oncology line $502,465. Doximity 2025 Physician Compensation Report (2024 data). https://www.doximity.com/reports/physician-compensation-report/2025 (2025) ↩ ↩2

  15. ASBrS 2014 expected income by practice setting — solo private $249,200; single-specialty $285,800; academic $308,500; multispecialty $346,600; hospital-employed $368,000 (2013 dollars). Annals of Surgical Oncology (2015). https://link.springer.com/article/10.1245/s10434-015-4720-z ↩ ↩2

  16. Pay structure / bonus + profit-sharing components. Payscale "Breast Surgical Oncologist" (page 2026 / underlying sample 2023 — treat as dated). https://www.payscale.com/research/US/Job=Breast_Surgical_Oncologist/Salary ↩

  17. Surgical-oncology burnout and satisfaction vs other surgical specialties. Balch et al., "Burnout and career satisfaction among surgical oncologists compared with other surgical specialties," Annals of Surgical Oncology (2011); PubMed 20953718. https://pubmed.ncbi.nlm.nih.gov/20953718/ ↩

  18. ~90% of fellows and ~62% of ASBrS members women; ~20% of general surgeons; historical "steering" and reputation. Medscape, "Glass Ceiling Shattered by Female Breast Surgeons" (2020). https://www.medscape.com/viewarticle/940147 (90% fellow figure is the widely-cited field estimate, not an official annual match table — ⟳ verify against a primary trainee census.) General-surgery residents, 49.9%: ACGME, Data Resource Book, Academic Year 2024-2025, Table C.21, which gives "Surgery 365 10,074 5,024 49.9% 4,995 49.6% 55 0.5%" — 365 programs, 10,074 active residents, 5,024 of them women. https://www.acgme.org/globalassets/pfassets/publicationsbooks/2024-2025_acgme_databook_document.pdf Corrected 2026-08-17: this page measured its central demographic claim against "~40% of general-surgery residents," ten points low and traceable to the 2020 Medscape article above rather than to a trainee census. General surgery residency is now at parity, so the trainee half of the contrast no longer works and the sentence says so; the practicing half, ~20%, still stands, and no citable current figure for it was found, which is why it keeps its ⟳. The ~90%-of-fellows figure is separately hedged in this footnote and that hedge is accurate: the SSO Breast Match statistics publish no sex breakdown. ↩ ↩2 ↩3 ↩4 ↩5

  19. ASBrS membership 62% female (2019); leadership representation at ASBrS annual meeting 2009–2019. "Has Breast Surgery Shattered the Glass Ceiling? Trends in Female Representation at the ASBrS Annual Meeting 2009–2019," Annals of Surgical Oncology (2020). https://link.springer.com/article/10.1245/s10434-020-08899-4 ↩ ↩2 ↩3

  20. BSO fellowship program directors 73% women / 27% men (60 programs). "Trends in leadership at breast surgical oncology fellowships," Global Surgical Education (2022); PubMed 38013714. https://pubmed.ncbi.nlm.nih.gov/38013714/ ; https://link.springer.com/article/10.1007/s44186-022-00046-9 ↩

  21. Valentina Bonev, "Reflections on My Journey to Becoming a Breast Surgeon," in-Training (2020). https://in-training.org/reflections-on-my-journey-to-becoming-a-breast-surgeon-27924 ↩

  22. ASBrS annual-meeting essay on skill-building and technique. Doximity Op-Med, "Learning an Essential Skill at the Annual Meeting of ASBrS." https://opmed.doximity.com/articles/learning-an-essential-skill-at-the-annual-meeting-of-asbrs ↩ ↩2

  23. Cryoablation / non-operative technique for the breast surgeon. Doximity Op-Med, "Pushing the Envelope: Cryoablation for the Breast Surgeon." https://opmed.doximity.com/articles/pushing-the-envelope-cryoablation-for-the-breast-surgeon ↩ ↩2

  24. FLI / breadwinner framing, sub-focuses (oncoplastic, high-risk/genetics), and "does fellowship pay?" context. "Fellowship Training After General Surgery Residency: Does it Pay?" Journal of Surgical Research (2025); PubMed 41206270. https://pubmed.ncbi.nlm.nih.gov/41206270/ Corrected 2026-08-18: an ASBrS compensation resource was cited beside the paper. That address now redirects to the society's home page, and the survey it described is a member-only benchmarking tool rather than a published figure, so nothing on this page rested on it and the pointer has been removed rather than left dangling. ↩ ↩2 ↩3 ↩4

Researched with AI assistance and reviewed by hand. How this site is made